Synthesis of meso-(4′-cyanophenyl) porphyrins: efficient photocytotoxicity against A549 cancer cells and their DNA interactions

Dalip Kumar*a, Bhupendra Mishraa, K. P. Chandrashekara, Santosh B. Khandagalea, Mukund P. Tantaka, Anil Kumara, Kanako Akamatsub, Eriko Kusakab, Kazuhito Tanabeb and Takeo Ito*b
aDepartment of Chemistry, Birla Institute of Technology and Science, Pilani 333 031, India. E-mail: E-dalipk@pilani.bits-pilani.ac.in
bDepartment of Energy and Hydrocarbon Chemistry, Graduate School of Engineering, Kyoto University, Kyoto 615-8510, Japan. E-mail: takeoito.kyoto@gmail.com

Received 18th February 2015 , Accepted 8th June 2015

First published on 8th June 2015


Abstract

We report a facile iodine(III)-mediated synthesis of cyanoporphyrins and their DNA photocleavage activity. Cationic-porphyrin 9a showed intercalative binding towards DNA, whereas Zn(II)-cyanoporphyrinate 9b showed outside electrostatic binding as indicated by their absorption and emission spectra. Porphyrin 9a displayed significant photocytotoxicity against A549 cancer cell line with an IC50 value of 54 nM.


Introduction

Porphyrins have been widely used for their applications in the fields of materials chemistry,1 biosensors,2 fluorescence imaging,3 medicine4 and photodynamic therapy (PDT)5,6 in particular. Cationic porphyrins have been exhaustively studied for their interactions with biomolecules like deoxyribonucleic acid (DNA), RNA and proteins.7,8 Among the cationic porphyrins reported so far, meso-tetrakis-(N-methyl-4-pyridyl)porphyrin (TMPyP) and its metallated analogues are thoroughly studied for their strong binding to G-quadruplex, triplex, duplex DNA and causing single strand or double strand cleavage in DNA upon irradiation with appropriate light in presence/absence of a reducing or oxidizing agent.9–11 Positively charged TMPyP exhibits distinct mode of binding towards DNA, such as (i) intercalation into the base pairs (ii) outside binding (iii) outside binding with self-stacking along the surface of the DNA apart from strong electrostatic attraction for the negatively charged base pairs.12 These abilities have earned these porphyrins applications in photodynamic therapy (PDT) as anti-cancer and anti-infective chemotherapeutic agents.13 Peripheral substituents at meso- and β-positions play a crucial role in determining the physico-chemical properties and hence, DNA binding modes of the porphyrin core.14,15 For the modulation of steric and electronic properties of porphyrins it is imperative to study the role of peripheral substituents. Substituting electron-withdrawing and donating groups on porphyrin macrocycles are expected to significantly affect their electronic and biological properties.16,17 Therefore, in recent years, immense efforts have been directed towards the synthesis of functionalized porphyrin derivatives.18,19 Hypervalent iodine reagents have been widely used as versatile and eco-friendly reagents with numerous applications in the synthesis of biologically important heterocycles. The increasing significance of hypervalent iodine reagents may be attributed to their low toxicity, ready availability, high efficiency and ease of experimentations.

Results and discussion

Based on our earlier report to prepare 3,5-bis(indolyl)-1,2,4-thiadiazoles20 in a single step and broaden its synthetic scope, we attempted IBD-mediated oxidative dimerization of porphyrin thioamide 5 in an effort to prepare bis(porphyrinyl)-1,2,4-thiadiazoles.21,22 However, oxidative dimerization of porphyrin thioamide 5 led to the exclusive formation of 5-(4′-cyanophenyl)-10,15,20-triarylporphyrin 7.

To our knowledge there is no report for the direct conversion of porphyrin thioamide to cyanoporphyrins, although the reports for oxidative dimerization of arylthioamides to 3,5-diarylthiadia-zoles using o-iodoxybenzoic acid discloses the formation of nitriles as side-products.23,24 In this manuscript, we report a facile protocol for the synthesis of 5-(4′-cyanophenyl)-10,15,20-triarylporphyrins 7 and 8 from readily available porphyrin thioamides 5 and 6 using iodobenzene diacetate (IBD). The porphyrin ester25 1 was hydrolyzed to give (4-carboxylphenyl)porphyrin, which upon treatment with thionyl chloride followed by purging of ammonia afforded the desired (carboxamidophenyl)porphyrin 3 (Scheme 1).22 Further reaction of (carboxamidophenyl)porphyrin 3 with Lawesson's reagent (LR) in toluene at 60 °C resulted in the formation of porphyrin thioamide 5.21 The IR spectrum of 5 exhibited a characteristic peak at 1618 cm−1 for C[double bond, length as m-dash]S stretching whereas, the C[double bond, length as m-dash]O stretching for carboxamide 3 appeared at 1666 cm−1. In similar steps, porphyrin thioamide 6, was prepared from porphyrin ester 2 as outlined in Scheme 1. The reaction of porphyrin thioamide 5 with equimolar quantity of IBD was initially attempted in acetonitrile, but the reaction was slow and did not complete owing to poor solubility of the starting material. However, the reaction proceeded smoothly in dimethylformamide (DMF) and dichloromethane (DCM) but we preferred the latter due to ease in isolation of cyanoporphyrins 7–8. For the formation of cyanoporphyrins 7–8, precursor porphyrin thioamide 6 is essential as IBD-mediated oxidations of arylamides have been described to generate corresponding arylamines.26 The resulting cyanoporphyrins 7 could be readily purified by washing with methanol, and 8 by a mixture of DCM–hexane.


image file: c5ra03075g-s1.tif
Scheme 1 Synthesis of 5-(4′-cyanophenyl)porphyrins (7–9). Reagents and conditions: (i) KOH, MeOH[thin space (1/6-em)]:[thin space (1/6-em)]H2O, 90 °C, 4 h; (ii) SOCl2, toluene, 110 °C, 1 h, then NH3(g), CH2Cl2, 0–25 °C, 45 min; (iii) 2,4-bis(4-methoxyphenyl)-1,3,2,4-dithiadiphosphetane-2,4-dithione (Lawesson's reagent), toluene/THF (6), 60 °C, 1 h; (iv) PhI(OAc)2, CH2Cl2, 25 °C, 45 min, then Zn(OAc)2 or Cu(OAc)2, CHCl3:MeOH, 65 °C, 1–2 h; (v) 8a and b, CH3I, CHCl3, 65 °C, 72 h.

The pyridyl groups in 8a and b were quaternized with methyl iodide in chloroform to obtain cationic porphyrins 9a and b. The porphyrins 7a–c and 9a and b were characterized by IR, ESI-MS and 1H NMR spectral data. The FT-IR spectra showed C[triple bond, length as m-dash]N stretching band at about 2227–2229 cm−1 for all the synthesized porphyrins 7–9. In the ESI-MS spectra, [M + H]+ ion peak was observed for porphyrin 7a–c and 9a and b. The β-pyrrolic and aromatic protons were also in agreement with the proposed structures as observed in 1H NMR (for spectral data see ESI). The 13C NMR of cyanoporphyrin 8a showed a characteristic signal at δ 114.9 ppm due to nitrile carbon, whereas; precursor porphyrin thioamide 6 exhibited a characteristic signal at δ 168.3 ppm for thioamide carbon. For further confirmation, we synthesized (4-cyano-phenyl)-tripyridylporphyrin 8a from the reaction of pyrrole with appropriate 4-cyanoarylaldehydes27–29 and the product obtained was found to be identical in all respects to porphyrin 8a. A probable pathway for the formation of cyanoporphyrins is shown in the Fig. 1. Nucleophilic attack of the sulphur atom of thioamide 5/6 on the electron-deficient iodine of IBD may form adduct [A] which rearranges to cyanoporphyrin 7/8 by the loss of sulphur, iodobenzene and acetic acid. Formation of expected bis(porphyrinyl)-1,2,4-thiadiazole would require the nucleophilic attack of another molecule of porphyrin thioamide on adduct [A], which would be sterically demanding due to the bulkier size of porphyrin thioamide. The interactions of porphyrins with calf thymus DNA (ctDNA) were studied using UV-vis and fluorescence spectroscopy. The spectral measurements were performed at 25 °C in Milli-Q water. Stock solutions for porphyrins 7–9 were prepared in dimethylformamide and ctDNA stock solution was prepared in buffer (5 mM Tris–HCl, pH 7.4). The absorption spectra of cyanoporphyrins 7 (5 μM) and 9 (2 μM) were recorded with increasing amounts of ctDNA (0–500 μM). The photophysical parameters did not exhibit any typical changes in absence of DNA for cyanoporphyrins 7a–c and 9a and b as compared to their metallated or free base counterparts, also they did not show aggregation in the Tris–HCl buffer at given concentrations (Fig. 2a, 3a and 4a). Absorption spectra of free base cyanoporphyrin 7a showed a bathochromic shift of 14 nm for the Soret band at λmax = 409 nm and hypochromicity of 16% (hypochromicity, H% = [(A0As)/A0] × 100, where A0 and As are absorbances at λmax of Soret bands for free and bound porphyrins, respectively) with increasing ctDNA (0–500 μM) concomitant with a moderate increase in its fluorescent intensity (Fig. 2a and b), indicative of outside binding or stacking along the ctDNA helix.20 Compounds 7b (λmax = 408 nm) and 7c (λmax = 409 nm) did not show significant changes in their UV-visible as well as emission spectra (see ESI).


image file: c5ra03075g-f1.tif
Fig. 1 A plausible mechanism for the formation of porphyrin 7/8.

image file: c5ra03075g-f2.tif
Fig. 2 (a) Absorption spectra of 7a (5 μM). (b) Emission spectra of 7a (5 μM). Arrows show the absorbance changes upon increasing the ctDNA concentration (pH 7.4).

image file: c5ra03075g-f3.tif
Fig. 3 (a) UV-vis spectra of 9a (2 μM). (b) Emission spectra of 9a (2 μM). Arrows show the absorbance changes upon increasing ctDNA concentration (pH 7.4).

image file: c5ra03075g-f4.tif
Fig. 4 (a) UV-vis spectra of 9b (2 μM). (b) Fluorescence spectra of 9b (2 μM). Arrows show the absorbance changes upon increasing ctDNA concentration (pH 7.4).

In the case of free base cationic porphyrin 9a the Soret band (λmax 421 nm) showed a red shift of 12 nm and hypochromicity of 36% and further at higher DNA/porphyrin ratios changed to a sharp peak at 433 nm (Fig. 3a).30–33 The fluorescence intensity increased gradually at lower DNA concentrations (0–8 μM) probably due to decrease in self-association of porphyrin molecules. At higher DNA concentrations (10–500 μM), the porphyrin self-assembly was disrupted and then monomeric forms got intercalated into DNA, thereby showing enhanced (14 times) fluorescent intensity (Fig. 3b). On the other hand, the absorption spectra of Zn(II)-cyanoporphyrinate 9b displayed lesser red shift (5 nm) and hypochromicity in the Soret band (λmax 434 nm), indicating binding through non-intercalating electrostatic interactions with the negatively charged DNA double helix.12,34,35 The possible presence of axial ligands blocked intercalative binding of 9b. This trend has been reported for Mn3+, Fe3+, Zn2+ and Co2+ complexes of porphyrins.12 The emission spectra of 9b (Fig. 4b) in a DNA-free environment exhibited an emission peak at 631 nm which upon increasing DNA concentration showed a blue shift with a moderate increase in intensity resembling outside binding with self-stacking along the DNA surface.36,37 The apparent binding constants (Kapp) were calculated based upon the changes in the UV-vis. absorption spectra of 7a, 9a and 9b upon addition of ctDNA in Tris–HCl buffer (pH 7.4). The corresponding binding constants were determined using the following equation.

image file: c5ra03075g-t1.tif

The molar absorption coefficients for the given solution, free porphyrin and for the porphyrin complex in fully bound form are εA, εF and εB, respectively. A plot of [DNA]/(εAεF) vs. [DNA] will have a slope of 1/(εBεF) and a y-axis intercept equal to 1/Kb(εBεF), Kb is binding constant. The binding constants of porphyrins 9a: 8.2 × 105 M−1 is comparable to H2TMPyP (7.7 × 105 M−1) and for zinc metallated 9b: 2.1 × 105 M−1 is less as compared to free base, presumably because zinc metallated complexes can accommodate axial ligands which sterically hinders association with DNA. Further, we studied the DNA cleavage activity of porphyrins 7a and b and 9a and b using agarose gel electrophoretic mobility assay. The photocleavage experiments were performed with high pressure Xe-arc through a band-path filter (λ = 300–390 nm, 4 mW, UV-A) or a white LED light source (λ = 400–800 nm, 2 mW, visible). Typically, a solution of ΦX174 DNA (0.5 μg) and an appropriate porphyrin in 20 mM Tris–HCl buffer (pH 7.2) containing 20 mM NaCl and 2.5 vol% DMSO (total volume 20 μL) was exposed to UV-A light at ambient temperature. The resultant mixtures were then analyzed by gel electrophoresis (1% agarose gel) with ethidium bromide staining. DNA cleavage was determined by the formation of relaxed circular DNA (form II). The DNA photocleavage studies of porphyrins 7a and c (1–20 μM) showed no visible photocleavage of circular DNA. However, cationic porphyrin 9a efficiently converted more than 95% of plasmid DNA from form I to form II upon 30 min of UV exposure (310–390 nm), on the other hand, 9b up to ∼85% (Fig. 5a). The DNA cleavage efficiency of porphyrins 9 (9a and 9b, 82% and 74% conversion, respectively) was almost comparable under visible light (>400 nm) and UV light (Fig. 5b).


image file: c5ra03075g-f5.tif
Fig. 5 Photoinduced DNA cleavage by 9a and 9b. ΦX174 supercoiled DNA (1.0 μg) was incubated with the porphyrins (1 μM) in 20 ml of Tris–HCl (20 mM, pH 7.2) containing NaCl (20 mM), DMSO (2.5 vol%) at ambient temperature in the dark for 30 min, and then (a) UV-irradiated (310–390 nm) for the indicated periods. Lane 1: DNA alone. (b) Exposed to visible light (>400 nm) for the indicated periods. Lane 1: DNA alone.

The DNA photocleavage studies of H2TMPyP (1 μM) under same conditions gave 38% conversion of form I to form II (see ESI). Very recently, Spingler et al. have also disclosed the cytotoxicity of tricationic cyanoporphyrins with nitrate counter anion towards A2780 and MCF-7 cancer cells (IC50 ∼ 0.4 μM). In this study, they have demonstrated that the excitation of tricationic cyanoporphyrins with red light leads to the generation of singlet oxygen, although we have not identified the reactive intermediates which induce DNA cleavage.38 WST method was used to evaluate the photocytotoxic potential of the cyanoporphyrins 9a and b upon photoexcitation on A549 lung cancer cells. The cytotoxicities were expressed as concentration of the compounds to kill 50% of the cells (IC50 μM). The cyanoporphyrins 9a and b upon incubation for 24 h at 37 °C, washed with PBS and subsequent LED irradiation led to significant decrease in the cell viability giving IC50 values of 54 nM for 9a and 77 nM for 9b, and >50 μM for both the porphyrins in dark (Fig. 6). Both the porphyrins were non-toxic in dark but exhibited significant cytotoxicity upon photoactivation. Further, the cyanoporphyrins 9a and b showed better efficacy (6 folds) than that of standard cationic photosensitizer H2TMPyP (IC50 0.3–1.24 μM).


image file: c5ra03075g-f6.tif
Fig. 6 Cell viability data of 9a and 9b in visible light.

Conclusions

In summary, we have developed a facile protocol for conversion of readily available porphyrin thioamides to cyanoporphyrins by utilizing a non-metallic and stable reagent, iodobenezene diacetate. Based on absorption studies it was found that more lipophilic cyanoporphyrin 7a bind towards ctDNA with moderate binding constant and has no photocleavage activity. However, both cationic cyanoporphyrins 9a and b bounds tightly to DNA and they exhibited significant photocytotoxicity at 1 μM concentration. At this stage of our research, it is still not clear whether the cyanoporphyrins target nuclear DNA in the living cells, but, the cationic cyanoporphyrins 9a and b showed efficient in vitro photocytotoxicity (54–77 nM) on A549 cells upon photo-activation. These preliminary results are quite promising and further structure–activity relationship studies of cyanoporphyrins with varying metals and peripheral substituents are likely to presage developing of novel cationic porphyrins as PDT agents.

Acknowledgements

We thank the Department of Science & Technology (DST), New Delhi for the financial support under DST-JSPS S&T Programme and University Grants Commission (UGC) for providing spectrofluorimeter facility under UGC-SAP project. BM is grateful to CSIR, New Delhi, for the award of SRF.

References

  1. K. S. Suslick, N. A. Rakow, M. E. Kosal and J.-H. Chou, J. Porphyrins Phthalocyanines, 2000, 4, 407 CrossRef CAS.
  2. B. Minaev and M. Lindgren, Sensors, 2009, 9, 1937 CrossRef CAS PubMed.
  3. J. E. Reeve, H. A. Collins, K. D. Mey, M. M. Kohl, K. J. Thorley, O. Paulsen, K. Clays and H. L. Anderson, J. Am. Chem. Soc., 2009, 131, 2758 CrossRef CAS PubMed.
  4. M. R. Detty, S. L. Gibson and S. J. Wagner, J. Med. Chem., 2004, 47, 3897 CrossRef CAS PubMed.
  5. A. Yavlovich, B. Smith, K. Gupta, R. Blumenthal and A. Puri, Mol. Membr. Biol., 2010, 27, 364 CrossRef CAS PubMed.
  6. D. Kessel and J. J. Reiners, Photochem. Photobiol., 2007, 83, 1024 CrossRef CAS PubMed.
  7. M. Schoonover and S. M. Kerwin, Bioorg. Med. Chem., 2012, 20, 6904 CrossRef CAS PubMed.
  8. A. A. Ghazaryan, Y. B. Dalyan, S. G. Haroutiunian, A. Tikhomirova, N. Taulier, J. W. Wells and T. V. Chalikian, J. Am. Chem. Soc., 2006, 128, 1914 CrossRef CAS PubMed.
  9. H. Wang and S. E. Rokita, Angew. Chem., Int. Ed., 2010, 49, 5957 CrossRef CAS PubMed.
  10. X. J. Zhu, P. Wang, H. W. C. Leung, W. K. Wong, W. Y. Wong and D. W. Kwong, Chem.–Eur. J., 2011, 17, 7041 CrossRef CAS PubMed.
  11. R. T. Wheelhouse, D. Sun, H. Han, F. X. Han and L. H. Hurley, J. Am. Chem. Soc., 1998, 120, 3261 CrossRef CAS.
  12. R. J. Fiel, J. Biomol. Struct. Dyn., 1989, 6, 1259 CAS.
  13. W. Williams, US Pat., 7642250, 2010.
  14. P. Kumari, N. Sinha, P. Chauhan and S. M. S. Chauhan, Curr. Org. Synth., 2011, 8, 393 CrossRef CAS.
  15. A. Serra, M. Pineiro, C. I. Santos, A. M. D. A. Rocha Gonsalves, M. Abrantes, M. Laranjo and M. F. Botelho, Photochem. Photobiol., 2010, 86, 206 CrossRef CAS PubMed.
  16. K. Suda, T. Kikkawa, S.-i. Nakajima and T. Takanami, J. Am. Chem. Soc., 2004, 126, 9554 CrossRef CAS PubMed.
  17. T. Takanami, M. Hayashi and K. Suda, Tetrahedron Lett., 2005, 46, 2893 CrossRef CAS PubMed.
  18. P. Silva, S. M. Fonseca, C. T. Arranja, H. D. Burrows, A. M. Urbano and A. J. Sobral, Photochem. Photobiol., 2010, 86, 1147 CrossRef CAS PubMed.
  19. S. Brittle, A. Flores, A. Hobson, A. Parnell, A. Dunbar, C. Hunter and T. Richardson, Soft Matter, 2012, 8, 2807 RSC.
  20. D. Kumar, N. M. Kumar, K.-H. Chang, R. Gupta and K. Shah, Bioorg. Med. Chem. Lett., 2011, 21, 5897 CrossRef CAS PubMed.
  21. D. Kumar, B. A. Mishra, K. C. Shekar, A. Kumar, K. Akamatsu, E. Kusaka and T. Ito, Chem. Commun., 2013, 49, 683 RSC.
  22. B. Mishra, K. P. C. Shekar, A. Kumar, S. Phukan, S. Mitra and D. Kumar, J. Heterocycl. Chem., 2013, 50, 125 CrossRef CAS PubMed.
  23. M. S. C. Pedras, S. Hossain and R. B. Snitynsky, Phytochemistry, 2011, 72, 199 CrossRef CAS PubMed.
  24. P. C. Patil, D. S. Bhalerao, P. S. Dangate and K. G. Akamanchi, Tetrahedron Lett., 2009, 50, 5820 CrossRef CAS PubMed.
  25. G. Garcia, V. Sarrazy, V. Sol, C. Le Morvan, R. Granet, S. Alves and P. Krausz, Bioorg. Med. Chem., 2009, 17, 767 CrossRef CAS PubMed.
  26. R. M. Moriarty, C. J. Chany, R. K. Vaid, O. Prakash and S. M. Tuladhar, J. Org. Chem., 1993, 58, 2478 CrossRef CAS.
  27. A. R. Genady and D. Gabel, Tetrahedron Lett., 2003, 44, 2915 CrossRef CAS.
  28. B. Steiger and F. C. Anson, Inorg. Chem., 1994, 33, 5767 CrossRef CAS.
  29. K. Wang, C. T. Poon, W. K. Wong, W. Y. Wong, C. Y. Choi, D. W. Kwong, H. Zhang and Z. Y. Li, Eur. J. Inorg. Chem., 2009, 2009, 922 CrossRef PubMed.
  30. S. Wu, Z. Li, L. Ren, B. Chen, F. Liang, X. Zhou, T. Jia and X. Cao, Bioorg. Med. Chem., 2006, 14, 2956 CrossRef CAS PubMed.
  31. J. Li, Y. Wei, L. Guo, C. Zhang, Y. Jiao, S. Shuang and C. Dong, Talanta, 2008, 76, 34 CrossRef CAS PubMed.
  32. R. Fiel, J. Howard, E. Mark and N. D. Gupta, Nucleic Acids Res., 1979, 6, 3093 CrossRef CAS PubMed.
  33. A. B. Guliaev and N. B. Leontis, Biochemistry, 1999, 38, 15425 CrossRef CAS PubMed.
  34. S. Mettath, B. R. Munson and R. K. Pandey, Bioconjugate Chem., 1999, 10, 94 CrossRef CAS PubMed.
  35. B. Ward, A. Skorobogaty and J. C. Dabrowiak, Biochemistry, 1986, 25, 7827 CrossRef CAS.
  36. K. Wang, T. Li, F. Yu, Y. Zheng, W. K. Wong, D. W. Kwong and Z. Li, Chin. J. Chem., 2012, 30, 529 CrossRef CAS PubMed.
  37. K. Ford, K. R. Fox, S. Neidle and M. J. Waring, Nucleic Acids Res., 1987, 15, 2221 CrossRef CAS PubMed.
  38. P. M. Antoni, A. Naik, I. Albert, R. Rubbiani, S. Gupta, P. Ruiz-Sanchez, P. Munikorn, J. M. Mateos, V. Luginbuehl, P. Thamyongkit, U. Ziegler, G. Gasser, G. Jeschke, P. Doz and B. Spingler, Chem.–Eur. J., 2015, 21, 1179 CrossRef CAS PubMed.

Footnote

Electronic supplementary information (ESI) available. See DOI: 10.1039/c5ra03075g

This journal is © The Royal Society of Chemistry 2015
Click here to see how this site uses Cookies. View our privacy policy here.